In The Cancer Genome Atlas, mutations in Hippo pathway components occur in approximately 10% of cancers, with the Hippo pathway listed as one of the 10 canonical signaling pathways most frequently altered in cancer, though mutations in YAP and TAZ themselves are rare (Sanchez-Vega et al. 2018). This evidence concerns the gene YAP1 and cancer.